Gliomas are primary malignant brain tumors of the central nervous system.
Glioma is a collective term for tumors originating from glial and neuronal cells of the nervous system, and is the most common malignant intracranial tumor, accounting for 40-50% of intracranial tumors. They can be classified as astrocytomas, oligodendrogliomas, mixed gliomas, and ventricular meningiomas according to the cell type.
The cause of glioma is unknown. Some known genetic diseases, such as neurofibromatosis (type I) and tuberous sclerosis, are genetic susceptibility factors for glioma. In addition, external environmental carcinogens such as electromagnetic radiation may also be associated with the development of glioma.
Different types of gliomas have different treatments and prognosis, and can usually be treated by surgery, radiotherapy and chemotherapy, and commonly used chemotherapeutic drugs include temozolomide.
This disease is highly specialized, should promptly go to regular hospitals, under the guidance of doctors to determine the specific treatment plan, and actively cooperate with the treatment to avoid deterioration of the condition.